Abstract
IT is well known that Fc receptors for IgG (FcRII) on macrophages mediate the endocytosis of antibody–antigen complexes and signal the release of inflammatory and cytotoxic agents1. FcRII are also expressed at high levels on B cells where they are less involved in endocytosis than in modulating B-cell activation by membrane immunoglobulins2,3. Although crosslinking of membrane immunoglobulins can result in B-cell differentiation and proliferation through stimulation of phospholipase C, mobilization of intracellular Ca2+, and activation of protein kinase C, crosslinking FcR with membrane immunoglobulins confers a dominant inhibitory signal that prevents or aborts activation2–6. This form of regulation may have a role in the induction of tolerance by IgG7 and in controlling the B-cell repertoire by anti-idiotypes8,9. The different functions of FcR on B cells and macrophages may reflect the fact that these cell types express closely related but distinct FcR isoforms. We have recently found that the main lymphocyte FcR isoform, FcRII-B1, is unable to mediate endocytosis by way of coated pits and coated vesicles owing to an in-frame insertion of 47 amino acids in its cytoplasmic tail10,11. Here we show that this insert, absent from the FcRII-B2 macrophage isoform, also contains serine phosphorylation sites that may have a role in the ability of FcR to regulate B-cell activation through membrane immunoglobulins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mellman, I. Curr. Opinion Immunol. 1, 16–25 (1988).
Klaus, G. G. B., Bijsterbosch, M. K., O'Garra, A., Harnett, M. M. & Rigley, K. P. Immunol. Rev. 99, 19–38 (1987).
Cambier, J. C. et al. Immunol. Rev. 95, 37–57 (1987).
Berridge, M. J. A. Rev. Biochem. 56, 159–193 (1987).
Phillips, N. E. & Parker, D. C. J. Immun. 132, 627–632 (1984).
Sinclair, N. R. S. & Panoskaltsis, A. Immunol. Today 8, 76–79 (1987).
Waldschmidt, T. J., Borel, Y. & Vitetta, E. S. J. Immun. 131, 2204–2209 (1983).
Sinclair, N. R. S. J. exp. Med. 129, 1183–1192 (1969).
Kohler, H., Richardson, B. C., Rowley, D. A. & Smyk, S. J. Immun. 119, 1979–1984 (1977).
Miettinen, H. M., Rose, J. K. & Mellman, I. Cell 58, 317–327 (1989).
Hunziker, W. & Mellman, I. J. Cell Biol. 109, 3291–3302 (1989).
Lewis, V. A., Koch, T., Plutner, H. & Mellman, I. Nature 324, 372–375 (1986).
Ravetch, J. V. et al. Science 234, 718–725 (1986).
Monroe, J. G. & Kass, M. J. J. Immun. 135, 1674 (1985).
Klaus, G. G. B., O'Garra, A., Bijsterbosch, M. K. & Holman, M. Eur. J. Immun. 16, 92 (1986).
Coggeshall, K. M. & Cambier, J. C. J. Immun. 133, 3382–3386 (1984).
Coggeshall, K. M. & Cambier, J. C. J. Immun. 134, 101–107 (1985).
Bijsterbosch, M. K. & Klaus, G. G. B. J. exp. Med. 162, 1825–1836 (1985).
Bijsterbosch, M. K., Meade, C. J., Turner, G. A. & Klaus, G. G. B. Cell 41, 999–1006 (1985).
Ransom, J. T. Harris, L. K. & Cambier, J. C. J. Immun. 137, 708–7715 (1986).
Nel, A. E. et al. Biochem. J. 233, 145–149 (1986).
Chen, Z. Z., Coggeshall, K. M. & Cambier, J. C. J. Immun. 136, 2300–2304 (1986).
Kim, K. J., Kanellopoulos-Langevin, C., Merwin, R. M., Sachs, D. H. & Asofsky, R. J. Immun. 122, 549–554 (1979).
Justement, L. B., Kreiger, J. & Cambier, J. C. J. Immun. 143, 881–889 (1989).
Parker, D. C. Immunol. Rev. 52, 115–130 (1980).
Wilson, H. A. et al. J. Immun. 138, 1712–1718 (1987).
Rigley, K. P., Harnett, M. M. & Klaus, G. G. B. Eur. J. Immunol. 19, 481–485 (1989).
Ukkonen, P., Lewis, V., Marsh, M., Helenius, A. & Mellman, I. J. exp. Med. 163, 952–971 (1986).
Tamaoki, T. et al. Biochem. biophys. Res. Commun. 135, 397–402 (1986).
Hogarth, P. M. et al. Immunogenetics 26, 161–168 (1987).
Hornbeck, P. & Paul, W. E. J. biol. Chem. 261, 14817–14824 (1986).
Ryan, J. L. & Henkart, P. A. in Regulatory Mechanisms in Lymphocyte Activation (ed. Lucas, D. O.) 4444 (Academic, New York, 1977).
Suzuki, T. R. et al. Biochemistry 19, 6037–6044 (1980).
Hirata, Y. & Suzuki, T. Biochemistry 26, 8189–8195 (1987).
Perussia, B. et al. J. exp. Med. 170, 73–86 (1989).
Pure, E., Witmer, M. D., Lum, J. B., Mellman, I. & Unkeless, J. C. J. Immun. 139, 4152–4158 (1987).
Stern, D. F., Heffernom, P. A. & Weinberg, R. A. Molec. cell. Biol. 6, 1729–1740 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunziker, W., Koch, T., Whitney, J. et al. Fc receptor phosphorylation during receptor-mediated control of B-cell activation. Nature 345, 628–632 (1990). https://doi.org/10.1038/345628a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/345628a0
This article is cited by
-
A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling
Nature (1994)
-
Fc receptor-mediated signal transduction
Journal of Clinical Immunology (1994)
-
The biology and pathology of Fc receptors
Journal of Clinical Immunology (1993)
-
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
Nature (1992)
-
Regulation of the expression of murine α- and β-FcγR genes
Immunologic Research (1992)